144 related articles for article (PubMed ID: 37304673)
1. Computational docking and
Otifi HM; Alshyarba M; Fayi MA; Dera AA; Rajagopalan P
Oncol Res; 2021; 29(3):217-227. PubMed ID: 37304673
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone attenuates phosphorylation of AKT to inhibit kidney cancer cell proliferation.
Dera A; Rajagopalan P
J Food Biochem; 2019 Apr; 43(4):e12793. PubMed ID: 31353586
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan-Induced Cytotoxicity via G
Tsujiya Y; Hasegawa A; Yamamori M; Okamura N
Biol Pharm Bull; 2021; 44(12):1878-1885. PubMed ID: 34853271
[TBL] [Abstract][Full Text] [Related]
5. Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway.
Wang T; Chen Z; Chen H; Yu X; Wang L; Liu X
J Ethnopharmacol; 2022 Apr; 288():115020. PubMed ID: 35066068
[TBL] [Abstract][Full Text] [Related]
6. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin inhibits viability of human renal carcinoma cells via the JAK2/STAT3 and PI3K/Akt pathway.
Xu Z; Wu D; Fu D; Tang C; Ge J; Zhang Z; Zhou W
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):199-203. PubMed ID: 33040836
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
He D; Yu Z; Liu S; Dai H; Xu Q; Li F
Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
[TBL] [Abstract][Full Text] [Related]
9. Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways.
Liu J; Li Q; Liu Z; Lin L; Zhang X; Cao M; Jiang J
Oncol Rep; 2016 Jun; 35(6):3363-70. PubMed ID: 27004568
[TBL] [Abstract][Full Text] [Related]
10. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo.
Wang S; Zhang C; Li Y; Li P; Zhang D; Li C
Cancer Chemother Pharmacol; 2019 Mar; 83(3):519-530. PubMed ID: 30542770
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
12. Galangin induced antitumor effects in human kidney tumor cells mediated via mitochondrial mediated apoptosis, inhibition of cell migration and invasion and targeting PI3K/ AKT/mTOR signalling pathway.
Zhu Y; Rao Q; Zhang X; Zhou X
J BUON; 2018; 23(3):795-799. PubMed ID: 30003754
[TBL] [Abstract][Full Text] [Related]
13. Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation.
Choi MJ; Park EJ; Oh JH; Min KJ; Yang ES; Kim YH; Lee TJ; Kim SH; Choi YH; Park JW; Kwon TK
Chem Biol Interact; 2011 Apr; 190(2-3):102-8. PubMed ID: 21334318
[TBL] [Abstract][Full Text] [Related]
14. FCX-146, a potent allosteric inhibitor of Akt kinase in cancer cells: Lead optimization of the second-generation arylidene indanone scaffold.
Balasubramaniam M; Lakkaniga NR; Dera AA; Fayi MA; Abohashrh M; Ahmad I; Chandramoorthy HC; Nalini G; Rajagopalan P
Biotechnol Appl Biochem; 2021 Feb; 68(1):82-91. PubMed ID: 32067263
[TBL] [Abstract][Full Text] [Related]
15. Dauricine inhibits viability and induces cell cycle arrest and apoptosis via inhibiting the PI3K/Akt signaling pathway in renal cell carcinoma cells.
Zhang S; Ren Y; Qiu J
Mol Med Rep; 2018 May; 17(5):7403-7408. PubMed ID: 29568902
[TBL] [Abstract][Full Text] [Related]
16. Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.
Holland WS; Tepper CG; Pietri JE; Chinn DC; Gandara DR; Mack PC; Lara PN
Cancer Chemother Pharmacol; 2012 Jan; 69(1):185-94. PubMed ID: 21644050
[TBL] [Abstract][Full Text] [Related]
17. Computational and in vitro characterization of ICY-5: A potential candidate promoting mitochondrial apoptosis via the c-MET and STAT3 pathways.
Al Shahrani M; Balasubramaniam M; Alshahrani MY; Saif A; Dera AA; Alasmari S; Abohassan M; Makkawi M; Radhakrishnan S; Rajagopalan P
J Cell Physiol; 2021 Jan; 236(1):146-156. PubMed ID: 32484605
[TBL] [Abstract][Full Text] [Related]
18. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
Wu WS; Chien CC; Chen YC; Chiu WT
PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
[TBL] [Abstract][Full Text] [Related]
19. IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-κB Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell.
Fayi MA; Alamri A; Rajagopalan P
Oncol Res; 2020 Mar; 28(2):177-189. PubMed ID: 31771696
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]